David P. Southwell, Director at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 115,464 shares at $14.91 ($1.7M) on 2018-12-07, disclosed to the SEC on 2018-12-10.
Open-market sale of $1.7M RCKT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.15 | 52,809 | $800K | 45.8% |
| 2 | $15.15 | 52,809 | $800K | 45.8% |
| 3 | $14.91 | 4,923 | $73K | 4.2% |
| 4 | $14.91 | 4,923 | $73K | 4.2% |
| Total | $15.13 avg | 115,464 | $1.7M | 100% |
| Filing → |
| PTCT | SELL | 2023-04-19 | $1.2M | — | Filing → |
| PTCT | SELL | 2023-04-04 | $257K | — | Filing → |
| PTCT | SELL | 2023-03-29 | $897K | — | Filing → |